Cargando…
COVID-19, coagulopathy and venous thromboembolism: more questions than answers
The acute respiratory illnesses caused by severe acquired respiratory syndrome corona Virus-2 (SARS-CoV-2) is a global health emergency, involving more than 8.6 million people worldwide with more than 450,000 deaths. Among the clinical manifestations of COVID-19, the disease that results from SARS-C...
Autores principales: | Marietta, Marco, Coluccio, Valeria, Luppi, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352087/ https://www.ncbi.nlm.nih.gov/pubmed/32653981 http://dx.doi.org/10.1007/s11739-020-02432-x |
Ejemplares similares
-
COVID-19, coagulopathy and venous thromboembolism: more questions than answers—comment
por: Ponzetto, Antonio, et al.
Publicado: (2020) -
Monkeypox outbreak: after COVID-19, another challenge for the hemostatic system?
por: Marietta, Marco, et al.
Publicado: (2022) -
Predictors of venous thromboembolism in COVID-19 patients: results of the COVID-19 Brazilian Registry
por: da Silveira, Warley Cezar, et al.
Publicado: (2022) -
COVID-19 coagulopathy: is it disseminated intravascular coagulation?
por: Levi, Marcel, et al.
Publicado: (2020) -
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy
por: Melazzini, Federica, et al.
Publicado: (2020)